The present disclosure relates to a calculation device for determining an interdialytic sodium intake of a patient and/or for determining a non-osmotically triggered interdialytic liquid intake, including a storage device and/or an input device configured for storing or for entering parameter values of the patient; a computing device, configured for calculating the interdialytic sodium intake of the patient and/or for calculating his non-osmotically triggered interdialytic liquid intake; and an output device for outputting a signal for controlling or closed-loop controlling a communication device and/or a medical blood treatment apparatus.

A medical fluid system includes a container holding a fluid at a level; and a radio frequency level sensor operably connected to the container and including an emitting electrode and a receiving electrode, the electrodes operating as a transmission line having an electrical impedance that varies with the level or volume of the fluid in the container, the level sensor configured to measure a phase shift of the transmission line, the phase shift indicative of the level or volume of the fluid in the container.

The present disclosure is related to a method and system for providing personalised haemodialysis for subject. The method includes obtaining concentration of electrolytes and of metabolic content in blood sample flowing into and out of dialyser through first blood bypass tube and second blood bypass tube, respectively. The first and the second blood bypass tube are arranged in first sensor and second sensor. Similarly, concentration of electrolytes and metabolic content in dialysate fluid flowing into and out of dialyser through first and second dialysate tube, respectively. The first dialysate tube and second dialysate tube are arranged to pass through third sensor and fourth sensor. Further, variations are identified in concentration obtained for electrolytes and metabolic content in blood sample with respect to concentration obtained for electrolytes and metabolic content in dialysate fluid, respectively. Thereafter, removal of electrolytes and metabolic content is performed from blood sample.

A fluid preparation apparatus for a renal failure treatment is disclosed. In an example, the fluid preparation apparatus includes an inlet configured to receive water from a water source and a fluid line fluidly connected to the inlet. The apparatus also includes a pump fluidly connected to the fluid line. The pump is configured to pump concentrate from a concentrate container to mix with the water to form a fluid mixture. The apparatus further includes a sensor configured to measure a composition characteristic of the fluid mixture. Additionally, the apparatus includes a controller operably coupled to the pump, the sensor, and a valve. The controller is configured to receive a composition characteristic value from the sensor, and cause the valve to route the fluid mixture for the renal failure treatment when the composition characteristic value indicates that the fluid mixture is suitable for the renal failure treatment.

The invention relates to a dialysis machine having an extracorporeal blood circuit, a blood pump, a dialyzer, a venous pressure sensor, a substituate line, and a control unit, wherein the control unit is configured to operate the blood pump in a first operating mode and in a special operating mode and to start the special operating mode after recognition of a trigger event, in which special operating mode a conveying rate of the blood pump is controlled by means of a default value or is regulated to a desired value, which default or desired value is derived from a value determined before the start of the currently started special operating mode or corresponds to said value, wherein the presence of at least one obstacle is polled before the start of the special operating mode, and wherein, on the presence of the obstacle, the start of the special operating mode is blocked or delayed and/or the selection of the default value or of the desire value on the presence of the obstacle differs from the selection without the presence of the obstacle.

The invention relates to a method and to a device for supplying a dialysis device with dialysate, and to a dialysis device comprising a device for supplying the dialysis device with dialysate. For producing dialysate, a container 13 filled with a pulverulent dialysate concentrate K is provided, the amount of dialysate concentrate in the container being set in such a way that an amount of dialysate sufficient for a specified number of dialysis treatments can be produced using the dialysate concentrate. The method according to the invention and the device according to the invention make it possible to align the amount K2 of concentrate in the container 13 and the planned consumption amount, which is dependent on the prescription from the doctor and the treatment parameters established by the machine. After the individual dialysis treatments have been carried out, it is continuously monitored whether the amount of concentrate is sufficient. It may be monitored whether the amount of concentrate is sufficient for the following treatment or for all treatments still to be carried out. If it is not sufficient, an alarm signal is generated. Otherwise, a control signal for initiating each of the next treatment cycles is generated.

A device for extracorporeal blood treatment comprising at least a first concentrate connection which is set up to feed at least a first concentrate into the device for extracorporeal blood treatment as the basis for generating a dialysate; at least a second concentrate connection which is configured to feed at least a second concentrate into the device for extracorporeal blood treatment as the basis for generating a dialysate; wherein the device for extracorporeal blood treatment is configured to switch over from supplying the at least first concentrate to supplying the at least second concentrate at a predetermined time or after a predetermined period of time during an ongoing blood treatment.

The present invention relates to devices, systems, and methods for controlling the concentration of potassium in dialysate in a closed loop potassium control system. The devices, systems, and methods can be compatible with any dialysis system including sorbent-based dialysis systems, single pass dialysis systems, or other multi-pass dialysis systems. The systems can use closed loop potassium control over potassium concentration in the dialysate to reduce the probability of patient arrhythmias. The potassium concentration can be controlled and personalized to a patient using certain predetermined patient parameters. Related systems, algorithms, and control systems are contemplated for optimizing the potassium concentration in the dialysate.

A device and method are used for monitoring an extracorporeal blood treatment device, such as a dialysis machine, which includes an extracorporeal blood circuit having an arterial blood line with an arterial patient port and/or at least one venous blood line with a venous patient port, and a dialysis fluid system which has a dialysis fluid supply line and a dialysis fluid drain line. The monitoring device selects and senses a measured value during operation of the extracorporeal blood treatment device which is suitable for monitoring the blood treatment device to compare a time-related actual course of the measured value with a target course of the measured value stored in a memory, and to determine that there is a defect if, at least in sections, the actual course of the measured value deviates from the target course by more than a defined tolerance.

An extracorporeal blood treatment apparatus is provided comprising a filtration unit connected to a blood circuit and to a dialysate circuit, a preparation device for preparing and regulating the composition of the dialysis fluid; a control unit is configured for receiving a desired sodium mass transport at the end of the treatment session and for setting the sodium concentration value for the dialysis fluid in the dialysis supply line at a set point to achieve the desired sodium mass transport at the end of the treatment session.